Alzheimer’s Research & Therapy, a new journal published by BioMed Central, is now accepting submissions.

Alzheimer’s Research & Therapy aims to be the major forum for translational research into Alzheimer’s disease. An international open access journal, Alzheimer’s Research & Therapy will publish basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. Although the journal’s primary focus is Alzheimer’s dementia, the scope will encompass other neurodegenerative disease. Review articles and expert commentary will accompany key papers.

The journal is edited by Professors Doug Galasko, Todd Golde and Gordon Wilcock, and supported by an international Editorial Board.

Alzheimer’s Research & Therapy forms part of BioMed Central’s growing portfolio of high quality, highly selective journals publishing translational research of exceptional interest, as well as authoritative reviews and commentaries. Other titles in this series include Arthritis Research & Therapy, which has established itself as one of the top ranked journals in rheumatology.

For more details on Alzheimer’s Research & Therapy please visit the journal ‘About‘ page or contact the editorial office. To keep abreast of the latest developments, and articles published in this exciting new journal, please register to receive regular alerts.

Submit your outstanding research now and take advantage of the rapid, high-quality peer review service, high visibility, as well as immediate and free access to all research papers.

Frances Mulvany
In-house Editor – Alzheimer’s Research & Therapy